BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8292072)

  • 1. Mammalian cell cultures. Part II: Genetic engineering, protein glycosylation, fermentation and process control.
    Werner RG; Noé W
    Arzneimittelforschung; 1993 Nov; 43(11):1242-9. PubMed ID: 8292072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate mammalian expression systems for biopharmaceuticals.
    Werner RG; Noé W; Kopp K; Schlüter M
    Arzneimittelforschung; 1998 Aug; 48(8):870-80. PubMed ID: 9748718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative and economic potential of mammalian cell culture.
    Werner RG
    Arzneimittelforschung; 1998 Apr; 48(4):423-6. PubMed ID: 9608886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of dynamic online fed-batch strategies on metabolism, productivity and N-glycosylation quality in CHO cell cultures.
    Chee Furng Wong D; Tin Kam Wong K; Tang Goh L; Kiat Heng C; Gek Sim Yap M
    Biotechnol Bioeng; 2005 Jan; 89(2):164-77. PubMed ID: 15593097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High-cell density cultivation of recombinant Escherichia coli for production of TRAIL by using a 2-stage feeding strategy].
    Zhang Y; Shen YL; Xia XX; Sun AY; Wei DZ; Zhou JS; Zhang GJ; Wang LH; Jiao BH
    Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):408-13. PubMed ID: 15971615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of production method and gene amplification on the glycosylation pattern of a secreted reporter protein in CHO cells.
    Lipscomb ML; Palomares LA; Hernández V; Ramírez OT; Kompala DS
    Biotechnol Prog; 2005; 21(1):40-9. PubMed ID: 15903239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal and consistent protein glycosylation in mammalian cell culture.
    Hossler P; Khattak SF; Li ZJ
    Glycobiology; 2009 Sep; 19(9):936-49. PubMed ID: 19494347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of fermentation on product consistency.
    Lubiniecki AS; Anumula K; Callaway J; L'Italien J; Oka M; Okita B; Wasserman G; Zabriskie D; Arathoon R; Builder S
    Dev Biol Stand; 1992; 76():105-15. PubMed ID: 1478331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian cell cultures. Part III: Safety and future aspects.
    Werner RG; Noé W
    Arzneimittelforschung; 1993 Dec; 43(12):1388-90. PubMed ID: 8141832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of long-term perfusion Chinese hamster ovary cell culture by glucose auxostat.
    Konstantinov KB; Tsai Y; Moles D; Matanguihan R
    Biotechnol Prog; 1996; 12(1):100-9. PubMed ID: 8845100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistency and stability of recombinant fermentations.
    Wiebe ME; Builder SE
    Dev Biol Stand; 1994; 83():45-54. PubMed ID: 7883099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioreactor and process design for large-scale mammalian cell culture manufacturing.
    Nelson KL; Geyer S
    Bioprocess Technol; 1991; 13():112-43. PubMed ID: 1367130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cell culture process changes on endogenous retrovirus expression.
    Brorson K; De Wit C; Hamilton E; Mustafa M; Swann PG; Kiss R; Taticek R; Polastri G; Stein KE; Xu Y
    Biotechnol Bioeng; 2002 Nov; 80(3):257-67. PubMed ID: 12226857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering mammalian cells in bioprocessing - current achievements and future perspectives.
    Lim Y; Wong NS; Lee YY; Ku SC; Wong DC; Yap MG
    Biotechnol Appl Biochem; 2010 Apr; 55(4):175-89. PubMed ID: 20392202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
    Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Process development for a recombinant Chinese hamster ovary (CHO) cell line utilizing a metal induced and amplified metallothionein expression system.
    Huang EP; Marquis CP; Gray PP
    Biotechnol Bioeng; 2004 Nov; 88(4):437-50. PubMed ID: 15459913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic approach for scale-down model development and characterization of commercial cell culture processes.
    Li F; Hashimura Y; Pendleton R; Harms J; Collins E; Lee B
    Biotechnol Prog; 2006; 22(3):696-703. PubMed ID: 16739951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-expression profiles for five key glycosylation genes for galactose-fed CHO cells expressing recombinant IL-4/13 cytokine trap.
    Clark KJ; Griffiths J; Bailey KM; Harcum SW
    Biotechnol Bioeng; 2005 Jun; 90(5):568-77. PubMed ID: 15818560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
    Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
    J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The preparation and validation of stock cultures of mammalian cells.
    Facklam TJ; Geyer S
    Bioprocess Technol; 1991; 13():54-85. PubMed ID: 1367151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.